News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Bitcoin’s $89K Reclaim Structural Shift Despite Bearish Flows
Cryptotale·2025/12/30 07:42
Uniswap price prediction – Is UNI holding the line after the fee switch vote?
AMBCrypto·2025/12/30 07:03
Lighter launches native token LIT, allocates half to ecosystem growth
The Block·2025/12/30 07:03
Chinese Analysis Firm Reveals: What’s the Latest Outlook for Bitcoin? Will There Be a Rally Before the New Year?
BitcoinSistemi·2025/12/30 06:57
Dive Into Dogecoin’s Decline as Year-End Sells Intensify
Cointurk·2025/12/30 06:42
Bitcoin Long-Term Holders Pause Selling as Ethereum Whales Launch Aggressive Accumulation Campaign
Bitcoinworld·2025/12/30 06:36
Lighter LIT Token Launch: Strategic Move for Decentralized Perpetual Futures Dominance
Bitcoinworld·2025/12/30 06:36
Beldex Price Prediction 2026-2030: Unveiling the Potential Hidden Gem in Privacy-Focused Cryptocurrencies
Bitcoinworld·2025/12/30 06:36
Ripple's RLUSD Booms While XRP Underforms
UToday·2025/12/30 06:30
Ripple Escrow Makes Price Shocks More Severe: Jake Claver
UToday·2025/12/30 06:30
Flash
12:56
Spot Gold Drops $14 in Short-Term Spot gold has fallen $14 in the short term, declining over 1.00% during the day, currently reported at $4133.10 per ounce. (Jin Shi)
12:52
Splash Beverage Group Inc. has successfully secured a $1 million strategic investment from C/M Capital Partners.This funding will be specifically allocated for the development of its Cannepil project.
12:51
Vivos (OTC market code: RDGL) has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) and will initiate a human clinical feasibility study of its Radiogel® Precision Radionuclide Therapy™.This approval marks a key step forward for the clinical application of this innovative therapy, allowing the company to begin initial safety and feasibility assessments in humans. The Radiogel® technology is designed to enable precise radiation treatment within tumors and is expected to provide a new treatment option for cancer patients. The approved clinical study will collect essential data to lay the foundation for larger-scale clinical trials in the future.
News